US Stock MarketDetailed Quotes

Amneal Pharmaceuticals (AMRX)

Watchlist

12.520
-0.130-1.03%

Close Apr 24 16:00 ET

12.480
-0.040-0.32%

Post 20:01 ET

3.99BMarket Cap56.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amneal Pharmaceuticals (AMRX) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

15.21%339.99M

10.36%130.32M

-16.45%118.45M

111.36%83.82M

267.98%7.41M

-14.61%295.1M

-13.06%118.08M

74.20%141.77M

449.55%39.66M

-103.16%-4.41M

Net income from continuing operations

273.17%127.93M

339.00%49.57M

54.22%18.13M

112.13%35.61M

130.14%24.62M

-51.63%-73.88M

77.78%-20.74M

-53.03%11.76M

-43.45%16.79M

-709.17%-81.68M

Operating gains losses

-203.64%-7.45M

-85.49%1.15M

213.16%3.21M

-1,544.11%-8.22M

-337.99%-3.6M

1,036.33%7.19M

440.84%7.95M

-190.72%-2.83M

33.57%569K

176.04%1.51M

Depreciation and amortization

-5.34%223.57M

-25.56%49.23M

-8.29%54.07M

8.17%60.11M

8.34%60.16M

2.96%236.19M

16.15%66.13M

3.07%58.96M

-2.69%55.57M

-4.51%55.53M

Other non cash items

1,253.50%59.76M

185.91%7.81M

2,113.48%41.88M

553.68%8.38M

2.56%1.68M

-90.06%4.42M

-91.44%2.73M

-77.71%1.89M

28.43%-1.85M

-75.04%1.64M

Change In working capital

-4,927.43%-204.52M

-156.23%-12.29M

-218.64%-50.74M

38.10%-35.11M

-788.42%-106.38M

91.38%-4.07M

-59.30%21.86M

223.12%42.77M

52.90%-56.72M

-122.06%-11.97M

-Change in receivables

25.64%-120.58M

65.55%-9.52M

-452.21%-77.34M

45.53%-54.87M

137.94%21.15M

-228.90%-162.16M

-135.49%-27.64M

213.16%21.96M

21.98%-100.74M

-128.37%-55.74M

-Change in inventory

33.33%-87.03M

61.18%-20.18M

28.52%-30.81M

2.03%-22.78M

-8.71%-13.26M

-3.45%-130.53M

-125.14%-51.99M

-1.25%-43.1M

38.85%-23.25M

45.80%-12.2M

-Change in prepaid assets

-1,898.23%-19.16M

-10.06%1.01M

-260.32%-10.16M

-388.81%-9.5M

95.62%-513K

-102.54%-959K

-91.36%1.12M

189.39%6.34M

20.16%3.29M

-140.15%-11.71M

-Change in payables and accrued expense

-92.32%22.25M

-83.66%16.4M

17.35%67.56M

-18.66%52.04M

-268.10%-113.75M

442.22%289.58M

812.31%100.36M

67.76%57.57M

45.52%63.98M

145.47%67.67M

Cash from discontinued investing activities

Operating cash flow

15.21%339.99M

10.36%130.32M

-16.45%118.45M

111.36%83.82M

267.98%7.41M

-14.61%295.1M

-13.06%118.08M

74.20%141.77M

449.55%39.66M

-103.16%-4.41M

Investing cash flow

Cash flow from continuing investing activities

-78.21%-112.26M

-183.04%-45.45M

-8.46%-22.46M

-310.63%-26.55M

9.93%-17.8M

8.95%-63M

49.33%-16.06M

-53.70%-20.71M

47.37%-6.47M

-68.36%-19.76M

Net PPE purchase and sale

-60.34%-96.75M

-88.99%-42.45M

12.05%-15.05M

-139.60%-25.65M

-35.17%-13.6M

-28.93%-60.34M

-90.50%-22.46M

-37.16%-17.11M

3.86%-10.7M

11.75%-10.06M

Net intangibles purchase and sale

-5.90%-15.51M

-400.00%-3M

-105.94%-7.41M

-20.00%-900K

56.70%-4.2M

34.56%-14.65M

96.98%-600K

-260.00%-3.6M

34.78%-750K

-2,769.82%-9.7M

Net business purchase and sale

--0

----

--11.99M

--7.01M

--0

----

Cash from discontinued investing activities

Investing cash flow

-78.21%-112.26M

-183.04%-45.45M

-8.46%-22.46M

-310.63%-26.55M

9.93%-17.8M

8.95%-63M

49.33%-16.06M

-53.70%-20.71M

47.37%-6.47M

-68.36%-19.76M

Financing cash flow

Cash flow from continuing financing activities

85.11%-31.53M

83.47%-10.12M

164.37%59.44M

-18.81%-41.69M

-69.15%-39.17M

0.37%-211.79M

39.30%-61.2M

-6.65%-92.35M

-186.28%-35.09M

-79.50%-23.16M

Net issuance payments of debt

154.69%101.24M

88.97%-6.12M

261.04%140.44M

42.41%-15.55M

-13.99%-17.53M

-917.23%-185.12M

-186.55%-55.54M

-61.67%-87.21M

-630.06%-27M

-309.47%-15.38M

Proceeds from stock option exercised by employees

69.84%1.96M

266.23%553K

5.83%653K

91.34%685K

146.43%69K

155.88%1.15M

251.16%151K

51.23%617K

--358K

--28K

Net other financing activities

-384.18%-134.73M

21.84%-4.55M

-1,319.29%-81.65M

-217.52%-26.82M

-178.08%-21.71M

88.19%-27.83M

96.47%-5.82M

82.59%-5.75M

51.31%-8.45M

61.43%-7.81M

Cash from discontinued financing activities

Financing cash flow

85.11%-31.53M

83.47%-10.12M

164.37%59.44M

-18.81%-41.69M

-69.15%-39.17M

0.37%-211.79M

39.30%-61.2M

-6.65%-92.35M

-186.28%-35.09M

-79.50%-23.16M

Net cash flow

Beginning cash position

19.49%118.42M

204.30%238.41M

68.62%83.67M

32.50%68.39M

19.49%118.42M

181.34%99.11M

-18.06%78.35M

-56.69%49.62M

-65.83%51.62M

181.34%99.11M

Current changes in cash

865.93%196.2M

83.12%74.74M

441.26%155.43M

922.86%15.59M

-4.71%-49.56M

-68.17%20.31M

1,137.19%40.82M

253.78%28.72M

94.72%-1.89M

-141.13%-47.33M

Effect of exchange rate changes

-68.17%-1.68M

71.76%-209K

-10,014.29%-694K

-203.96%-307K

-184.85%-470K

-1,636.92%-999K

-468.16%-740K

102.33%7K

83.22%-101K

-121.51%-165K

End cash Position

164.26%312.94M

204.30%238.41M

68.62%83.67M

32.50%68.39M

19.49%118.42M

-18.06%78.35M

-56.69%49.62M

-65.83%51.62M

Free cash flow

2.51%225.64M

-11.44%84.15M

-20.71%95.99M

100.04%56.42M

54.84%-10.91M

-20.36%220.11M

-8.76%95.01M

78.27%121.06M

219.36%28.2M

-118.89%-24.17M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	15.21%339.99M	10.36%130.32M	-16.45%118.45M	111.36%83.82M	267.98%7.41M	-14.61%295.1M	-13.06%118.08M	74.20%141.77M	449.55%39.66M	-103.16%-4.41M
Net income from continuing operations	273.17%127.93M	339.00%49.57M	54.22%18.13M	112.13%35.61M	130.14%24.62M	-51.63%-73.88M	77.78%-20.74M	-53.03%11.76M	-43.45%16.79M	-709.17%-81.68M
Operating gains losses	-203.64%-7.45M	-85.49%1.15M	213.16%3.21M	-1,544.11%-8.22M	-337.99%-3.6M	1,036.33%7.19M	440.84%7.95M	-190.72%-2.83M	33.57%569K	176.04%1.51M
Depreciation and amortization	-5.34%223.57M	-25.56%49.23M	-8.29%54.07M	8.17%60.11M	8.34%60.16M	2.96%236.19M	16.15%66.13M	3.07%58.96M	-2.69%55.57M	-4.51%55.53M
Other non cash items	1,253.50%59.76M	185.91%7.81M	2,113.48%41.88M	553.68%8.38M	2.56%1.68M	-90.06%4.42M	-91.44%2.73M	-77.71%1.89M	28.43%-1.85M	-75.04%1.64M
Change In working capital	-4,927.43%-204.52M	-156.23%-12.29M	-218.64%-50.74M	38.10%-35.11M	-788.42%-106.38M	91.38%-4.07M	-59.30%21.86M	223.12%42.77M	52.90%-56.72M	-122.06%-11.97M
-Change in receivables	25.64%-120.58M	65.55%-9.52M	-452.21%-77.34M	45.53%-54.87M	137.94%21.15M	-228.90%-162.16M	-135.49%-27.64M	213.16%21.96M	21.98%-100.74M	-128.37%-55.74M
-Change in inventory	33.33%-87.03M	61.18%-20.18M	28.52%-30.81M	2.03%-22.78M	-8.71%-13.26M	-3.45%-130.53M	-125.14%-51.99M	-1.25%-43.1M	38.85%-23.25M	45.80%-12.2M
-Change in prepaid assets	-1,898.23%-19.16M	-10.06%1.01M	-260.32%-10.16M	-388.81%-9.5M	95.62%-513K	-102.54%-959K	-91.36%1.12M	189.39%6.34M	20.16%3.29M	-140.15%-11.71M
-Change in payables and accrued expense	-92.32%22.25M	-83.66%16.4M	17.35%67.56M	-18.66%52.04M	-268.10%-113.75M	442.22%289.58M	812.31%100.36M	67.76%57.57M	45.52%63.98M	145.47%67.67M
Cash from discontinued investing activities
Operating cash flow	15.21%339.99M	10.36%130.32M	-16.45%118.45M	111.36%83.82M	267.98%7.41M	-14.61%295.1M	-13.06%118.08M	74.20%141.77M	449.55%39.66M	-103.16%-4.41M
Investing cash flow
Cash flow from continuing investing activities	-78.21%-112.26M	-183.04%-45.45M	-8.46%-22.46M	-310.63%-26.55M	9.93%-17.8M	8.95%-63M	49.33%-16.06M	-53.70%-20.71M	47.37%-6.47M	-68.36%-19.76M
Net PPE purchase and sale	-60.34%-96.75M	-88.99%-42.45M	12.05%-15.05M	-139.60%-25.65M	-35.17%-13.6M	-28.93%-60.34M	-90.50%-22.46M	-37.16%-17.11M	3.86%-10.7M	11.75%-10.06M
Net intangibles purchase and sale	-5.90%-15.51M	-400.00%-3M	-105.94%-7.41M	-20.00%-900K	56.70%-4.2M	34.56%-14.65M	96.98%-600K	-260.00%-3.6M	34.78%-750K	-2,769.82%-9.7M
Net business purchase and sale	--0	--0	--0	----	----	--11.99M	--7.01M	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-78.21%-112.26M	-183.04%-45.45M	-8.46%-22.46M	-310.63%-26.55M	9.93%-17.8M	8.95%-63M	49.33%-16.06M	-53.70%-20.71M	47.37%-6.47M	-68.36%-19.76M
Financing cash flow
Cash flow from continuing financing activities	85.11%-31.53M	83.47%-10.12M	164.37%59.44M	-18.81%-41.69M	-69.15%-39.17M	0.37%-211.79M	39.30%-61.2M	-6.65%-92.35M	-186.28%-35.09M	-79.50%-23.16M
Net issuance payments of debt	154.69%101.24M	88.97%-6.12M	261.04%140.44M	42.41%-15.55M	-13.99%-17.53M	-917.23%-185.12M	-186.55%-55.54M	-61.67%-87.21M	-630.06%-27M	-309.47%-15.38M
Proceeds from stock option exercised by employees	69.84%1.96M	266.23%553K	5.83%653K	91.34%685K	146.43%69K	155.88%1.15M	251.16%151K	51.23%617K	--358K	--28K
Net other financing activities	-384.18%-134.73M	21.84%-4.55M	-1,319.29%-81.65M	-217.52%-26.82M	-178.08%-21.71M	88.19%-27.83M	96.47%-5.82M	82.59%-5.75M	51.31%-8.45M	61.43%-7.81M
Cash from discontinued financing activities
Financing cash flow	85.11%-31.53M	83.47%-10.12M	164.37%59.44M	-18.81%-41.69M	-69.15%-39.17M	0.37%-211.79M	39.30%-61.2M	-6.65%-92.35M	-186.28%-35.09M	-79.50%-23.16M
Net cash flow
Beginning cash position	19.49%118.42M	204.30%238.41M	68.62%83.67M	32.50%68.39M	19.49%118.42M	181.34%99.11M	-18.06%78.35M	-56.69%49.62M	-65.83%51.62M	181.34%99.11M
Current changes in cash	865.93%196.2M	83.12%74.74M	441.26%155.43M	922.86%15.59M	-4.71%-49.56M	-68.17%20.31M	1,137.19%40.82M	253.78%28.72M	94.72%-1.89M	-141.13%-47.33M
Effect of exchange rate changes	-68.17%-1.68M	71.76%-209K	-10,014.29%-694K	-203.96%-307K	-184.85%-470K	-1,636.92%-999K	-468.16%-740K	102.33%7K	83.22%-101K	-121.51%-165K
End cash Position	164.26%312.94M	164.26%312.94M	204.30%238.41M	68.62%83.67M	32.50%68.39M	19.49%118.42M	19.49%118.42M	-18.06%78.35M	-56.69%49.62M	-65.83%51.62M
Free cash flow	2.51%225.64M	-11.44%84.15M	-20.71%95.99M	100.04%56.42M	54.84%-10.91M	-20.36%220.11M	-8.76%95.01M	78.27%121.06M	219.36%28.2M	-118.89%-24.17M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

United Microelectronics

Middle East conflict spreads to the stock market! How should investors respond?

Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm